Trial Profile
Phase 2 Study of Pemetrexed in Combination With Cisplatin and Cetuximab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Cetuximab; Cisplatin; Cisplatin cholylglycinate; Cobalamin; Folic acid
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 18 Oct 2012 Planned End Date changed from 1 Dec 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 02 Aug 2012 Planned End Date changed from 1 Jul 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 22 Mar 2012 Planned end date changed from 1 Apr 2012 to 1 Jul 2012 as reported by ClinicalTrials.gov.